William C. Kisseberth

Medicine · Health Sciences

37h-index3.9kcitations153works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Veterinary Oncology Research(77), Virus-based gene therapy research(64), Sarcoma Diagnosis and Treatment(32), Infectious Diseases and Mycology(23), Cancer Research and Treatments(15)

Publications153 total

Soft Tissue Sarcoma
2026
OSU-ERβ-12: a promising pre-clinical candidate selective estrogen receptor beta agonist
Scientific Reports·2025Open Access
Diagnosis and Classification of Primary Nodal Lymphomas in Dogs: A Consensus of the Oncology‐Pathology Working Group
Veterinary and Comparative Oncology·2025· 1 citedOpen Access
Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2
Molecular Therapy·2025· 7 cited
Contributors
Elsevier eBooks·2024Open Access
Evaluation of SOX-10 immunohistochemical expression in canine melanoma and non-melanocytic tumors by tissue microarray
Veterinary Pathology·2024· 6 cited
Cover Image
Veterinary and Comparative Oncology·2023Open Access
Establishment and characterization of two novel patient‐derived lines from canine high‐grade glioma
Veterinary and Comparative Oncology·2023· 3 citedOpen Access
Supplementary Table 5 from <i>SETD2</i> Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma
2023Open Access
Data from NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma
2023Open Access
Supplementary Figure 2 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 1 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 3 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Figure 1 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Table 1 from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
2023Open Access
Supplementary Data from NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma
2023Open Access
Supplementary Table 14 from <i>SETD2</i> Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma
2023Open Access
Supplementary Tables 1-14 from <i>SETD2</i> Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma
2023Open Access
Supplementary Figures 1-8 from <i>SETD2</i> Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma
2023Open Access
Supplementary Table 5 from <i>SETD2</i> Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Cheryl A. London(28), Jaime F. Modiano(10), David M. Vail(10), Matthew Breen(9), Misty D. Bear(9), C. Guillermo Couto(9), Antonella Borgatti(6), Kenji Hosoya(6), Susan E. Lana(6), Sridhar Murahari(6), Joelle M. Fenger(5), Rachael Thomas(5), Stuart C. Helfand(5), Francisco J. Álvarez(5), Ana Lara‐Garcia(5), Christina Mazcko(5), Kerstin Lindblad‐Toh(4), E. Gregory MacEwen(4), Joyce E. Obradovich(4), Kristine Burgess(4)